• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天免疫和微生物群在肝纤维化中的作用:肝脏和肠道之间的串扰。

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

机构信息

Division of Gastroenterology, Department of Medicine, University of California, San Diego, School of Medicine, 9500 Gilman Drive, MC no. 0702, Leichtag Biomedical Research Building, Room no. 118B, La Jolla, CA 92093-0702, USA.

出版信息

J Physiol. 2012 Feb 1;590(3):447-58. doi: 10.1113/jphysiol.2011.219691. Epub 2011 Nov 28.

DOI:10.1113/jphysiol.2011.219691
PMID:22124143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3379693/
Abstract

Liver fibrosis occurs as a wound-healing scar response following chronic liver inflammation including alcoholic liver disease, non-alcoholic steatohepatitis, viral hepatitis, cholestatic liver disease and autoimmune liver diseases. The liver has a unique vascular system within the gastrointestinal tract, as the majority of the liver's blood supply comes from the intestine through the portal vein. When the intestinal barrier function is disrupted, an increase in intestinal permeability leads to the translocation of intestine-derived bacterial products such as lipopolysaccharide (LPS) and unmethylated CpG containing DNA to the liver via the portal vein. These gut-derived bacterial products stimulate innate immune receptors, namely Toll-like receptors (TLRs), in the liver. TLRs are expressed on Kupffer cells, endothelial cells, dendritic cells, biliary epithelial cells, hepatic stellate cells, and hepatocytes. TLRs activate these cells to contribute to acute and chronic liver diseases. This review summarizes recent studies investigating the role of TLRs, intestinal microbiota and bacterial translocation in liver fibrosis, alcoholic liver disease and non-alcoholic steatohepatitis.

摘要

肝纤维化是一种慢性肝炎症(包括酒精性肝病、非酒精性脂肪性肝炎、病毒性肝炎、胆汁淤积性肝病和自身免疫性肝病)后的伤口愈合疤痕反应。肝脏在胃肠道内具有独特的血管系统,因为肝脏的大部分血液供应来自肠道,通过门静脉进入肝脏。当肠道屏障功能被破坏时,肠道通透性增加会导致肠道来源的细菌产物(如脂多糖[LPS]和含有未甲基化 CpG 的 DNA)通过门静脉转移到肝脏。这些肠道来源的细菌产物刺激肝脏中的先天免疫受体,即 Toll 样受体(TLRs)。TLRs 表达于枯否细胞、内皮细胞、树突状细胞、胆管上皮细胞、肝星状细胞和肝细胞。TLRs 激活这些细胞,导致急性和慢性肝病的发生。本文综述了最近关于 TLRs、肠道微生物群和细菌易位在肝纤维化、酒精性肝病和非酒精性脂肪性肝炎中的作用的研究。

相似文献

1
Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.先天免疫和微生物群在肝纤维化中的作用:肝脏和肠道之间的串扰。
J Physiol. 2012 Feb 1;590(3):447-58. doi: 10.1113/jphysiol.2011.219691. Epub 2011 Nov 28.
2
Toll-like receptor signaling and liver fibrosis. toll 样受体信号转导与肝纤维化
Gastroenterol Res Pract. 2010;2010. doi: 10.1155/2010/192543. Epub 2010 Jul 25.
3
Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies.肠-肝轴与非酒精性脂肪性肝病纤维化:新型治疗方法的切入点。
Dig Liver Dis. 2013 Jul;45(7):543-51. doi: 10.1016/j.dld.2012.11.010. Epub 2012 Dec 29.
4
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.非酒精性或酒精性脂肪性肝炎所致肝损伤发展进程中的常见致病机制。
J Toxicol Sci. 2007 Dec;32(5):453-68. doi: 10.2131/jts.32.453.
5
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.肠-肝轴在肝硬化和门静脉高压发病机制中的作用。
Clin Mol Hepatol. 2012 Dec;18(4):337-46. doi: 10.3350/cmh.2012.18.4.337. Epub 2012 Dec 21.
6
The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression.肠道来源的微生物抗原在肝纤维化的发生和进展中的作用。
Cells. 2019 Oct 27;8(11):1324. doi: 10.3390/cells8111324.
7
Role of toll-like receptors in immune activation and tolerance in the liver.Toll样受体在肝脏免疫激活与耐受中的作用。
Front Immunol. 2014 May 16;5:221. doi: 10.3389/fimmu.2014.00221. eCollection 2014.
8
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.肠-肝轴、肝硬化和门静脉高压:先有鸡还是先有蛋。
Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26.
9
Toll-like receptors in acute liver injury and regeneration. toll 样受体在急性肝损伤与再生中的作用。
Int Immunopharmacol. 2011 Oct;11(10):1433-41. doi: 10.1016/j.intimp.2011.04.023. Epub 2011 May 19.
10
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).酒精性肝病的治疗策略:聚焦于炎症和纤维化(综述)。
Int J Mol Med. 2017 Aug;40(2):263-270. doi: 10.3892/ijmm.2017.3015. Epub 2017 Jun 9.

引用本文的文献

1
The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases.熊去氧胆酸(UDCA)对慢性胆汁淤积性肝病患者血清中miR-34a和miR-506表达的影响
Cells. 2025 Jul 23;14(15):1137. doi: 10.3390/cells14151137.
2
Spontaneous Bacterial Peritonitis in Advanced Cirrhosis: Diagnosis by Tm Mapping and Inflammatory Profiles of Extracellular Vesicles.晚期肝硬化自发性细菌性腹膜炎:通过Tm映射和细胞外囊泡炎症谱进行诊断
J Clin Med. 2025 Jul 17;14(14):5096. doi: 10.3390/jcm14145096.
3
Polysaccharides Ameliorate DSS-Induced Colitis by Restoring Intestinal Barrier Function and Reprogramming Immune Homeostasis via the Gut-Liver Axis.多糖通过恢复肠道屏障功能并经由肠-肝轴重新编程免疫稳态来改善右旋糖酐硫酸酯钠诱导的结肠炎。
Int J Mol Sci. 2025 Jul 16;26(14):6805. doi: 10.3390/ijms26146805.
4
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.基于纳米颗粒的慢性肝病治疗策略:进展与见解
Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun.
5
and are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.并且与肠道微生物群的老化相关联,并影响免疫检查点抑制剂的疗效。
Front Immunol. 2025 May 22;16:1528521. doi: 10.3389/fimmu.2025.1528521. eCollection 2025.
6
Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions.解析代谢相关脂肪性肝病:肠道微生物群、饮食调节及人工智能驱动的生活方式干预的作用
Nutrients. 2025 May 4;17(9):1580. doi: 10.3390/nu17091580.
7
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.美国胃肠病学会临床指南:肝病中的营养不良与营养建议
Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2.
8
Scutellarin Alleviates CCl-Induced Liver Fibrosis by Regulating Intestinal Flora and PI3K/AKT Signaling Axis.灯盏花素通过调节肠道菌群和PI3K/AKT信号轴减轻四氯化碳诱导的肝纤维化
Int J Mol Sci. 2025 Mar 25;26(7):2997. doi: 10.3390/ijms26072997.
9
Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases.甜菜碱调节肠-肝轴:一种慢性肝病的治疗方法。
Front Nutr. 2025 Mar 24;12:1478542. doi: 10.3389/fnut.2025.1478542. eCollection 2025.
10
The critical role of the ZBP1-NINJ1 axis and IRF1/IRF9 in ethanol-induced cell death, PANoptosis, and alcohol-associated liver disease.ZBP1-NINJ1轴以及IRF1/IRF9在乙醇诱导的细胞死亡、PAN凋亡和酒精性肝病中的关键作用。
bioRxiv. 2025 Mar 14:2025.03.12.642836. doi: 10.1101/2025.03.12.642836.

本文引用的文献

1
Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis.肠道微生物失调与 CCl4 诱导纤维化小鼠的炎症和细菌易位有关。
PLoS One. 2011;6(7):e23037. doi: 10.1371/journal.pone.0023037. Epub 2011 Jul 29.
2
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.化学趋化因子 CCL2(单核细胞趋化蛋白 1)的药理学抑制可减少慢性肝损伤中的肝巨噬细胞浸润和脂肪性肝炎。
Gut. 2012 Mar;61(3):416-26. doi: 10.1136/gutjnl-2011-300304. Epub 2011 Aug 3.
3
Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.核因子高迁移率族盒 1 介导非酒精性脂肪性肝病早期小鼠肝细胞 Toll 样受体 4 信号通路的激活。
Hepatology. 2011 Nov;54(5):1620-30. doi: 10.1002/hep.24552. Epub 2011 Jul 25.
4
Characterization of fecal microbial communities in patients with liver cirrhosis.肝硬化患者粪便微生物群落的特征。
Hepatology. 2011 Aug;54(2):562-72. doi: 10.1002/hep.24423. Epub 2011 Jun 26.
5
Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.Toll 样受体 4 通过小鼠骨髓来源的和内源性的肝细胞介导酒精性脂肪性肝炎。
Alcohol Clin Exp Res. 2011 Aug;35(8):1509-18. doi: 10.1111/j.1530-0277.2011.01487.x. Epub 2011 Apr 4.
6
Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.检测乙型肝炎病毒感染肝硬化患者的肠道微生物群。HBV 肝硬化患者的肠道微生物群。
Microb Ecol. 2011 Apr;61(3):693-703. doi: 10.1007/s00248-010-9801-8. Epub 2011 Feb 1.
7
Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.干扰素调节因子 3 和 I 型干扰素通过实质细胞和髓样细胞的串扰在小鼠酒精性肝损伤中起保护作用。
Hepatology. 2011 Feb;53(2):649-60. doi: 10.1002/hep.24059. Epub 2011 Jan 10.
8
Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. toll-样受体及其下游分子在非酒精性脂肪性肝病发生发展中的作用。
Gastroenterol Res Pract. 2010;2010:362847. doi: 10.1155/2010/362847. Epub 2011 Jan 17.
9
Enteric dysbiosis associated with a mouse model of alcoholic liver disease.酒精性肝病小鼠模型相关的肠道菌群失调。
Hepatology. 2011 Jan;53(1):96-105. doi: 10.1002/hep.24018. Epub 2010 Dec 10.
10
Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.髓样分化因子-2 和 Toll 样受体 4 表达缺失可减轻小鼠非酒精性脂肪性肝炎和肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2011 Mar;300(3):G433-41. doi: 10.1152/ajpgi.00163.2009. Epub 2011 Jan 13.